InnovAge Holding Corp. INNV
8.84 USD -0.08 (-0.87%)
Nov 3, 2026, 3:56 PM EST
8.78 Day range 9.25
3.94 52-week range 12.64
- YTD
- +70.37%
- 1 year
- +86.54%
Analyst view
Price target (mean) 12.00 +35.7% upside
Now 8.84
- Target (low)
- 10.00
- Target (mean)
- 12.00
- Target (high)
- 14.00
Ratings (0m) 3 1 buy · 1 hold · 1 sell
- Strong buy0
- Buy1
- Hold1
- Sell0
- Strong sell1
Recommendation trend
- This month 3
- 1 month ago 3
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.09 | 0.09 – 0.09 | 0.0698 | +28.9% | 255.85M | +8.4% | 1 |
| Next quarter | 0.09 | 0.09 – 0.09 | 0.0976 | -7.8% | 261.10M | +8.9% | 1 |
| Current year | 0.45 | 0.45 – 0.45 | 0.4476 | +0.5% | 1.07B | +8.5% | 1 |
| Next year | 0.50 | 0.50 – 0.50 | 0.45 | +11.1% | 1.16B | +8.0% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 9, 2026 | Keybanc | Maintained | Overweight | Overweight |
| Aug 21, 2026 | Keybanc | Upgrade | Sector Weight | Overweight |
| Feb 23, 2026 | JP Morgan | Maintained | Underweight | Underweight |
| Dec 17, 2024 | JP Morgan | Downgrade | Neutral | Underweight |
| Mar 13, 2024 | JP Morgan | Maintained | Neutral | Neutral |
| Feb 8, 2024 | Goldman Sachs | Maintained | Neutral | Neutral |
| Feb 15, 2023 | Goldman Sachs | Maintained | — | Neutral |
| Feb 8, 2023 | JP Morgan | Maintained | — | Neutral |
| Nov 23, 2022 | Goldman Sachs | Maintained | — | Neutral |
| Nov 16, 2022 | Citigroup | Maintained | — | Neutral |
| Sep 15, 2022 | Barclays | Maintained | — | Equal-Weight |
| May 16, 2022 | Baird | Downgrade | Outperform | Neutral |
| May 11, 2022 | Piper Sandler | Maintained | — | Underweight |
| Apr 20, 2022 | Piper Sandler | Downgrade | Neutral | Underweight |
| Dec 28, 2021 | Goldman Sachs | Downgrade | Buy | Neutral |
| Dec 27, 2021 | Barclays | Downgrade | Overweight | Equal-Weight |
| Dec 17, 2021 | JP Morgan | Initiated | — | Neutral |
| Sep 29, 2021 | Citigroup | Downgrade | Buy | Neutral |
| Sep 22, 2021 | William Blair | Downgrade | Outperform | Market Perform |
| Sep 10, 2021 | Cowen & Co. | Initiated | — | Market Perform |
| Aug 12, 2021 | Barclays | Upgrade | Equal-Weight | Overweight |
| May 28, 2021 | Baird | Initiated | — | Outperform |
| Mar 29, 2021 | Goldman Sachs | Initiated | — | Buy |
| Mar 29, 2021 | Barclays | Initiated | — | Equal-Weight |
| Mar 29, 2021 | Citigroup | Initiated | — | Buy |
| Mar 29, 2021 | William Blair | Initiated | — | Outperform |
| Mar 29, 2021 | Piper Sandler | Initiated | — | Overweight |